rs12130333
Orientation | plus |
Stabilized | plus |
Make rs12130333(C;C) |
Make rs12130333(C;T) |
Make rs12130333(T;T) |
Reference | GRCh38 38.1/141 |
Chromosome | 1 |
Position | 62726106 |
is a | snp |
is | mentioned by |
dbSNP | rs12130333 |
dbSNP (classic) | rs12130333 |
ClinGen | rs12130333 |
ebi | rs12130333 |
HLI | rs12130333 |
Exac | rs12130333 |
Gnomad | rs12130333 |
Varsome | rs12130333 |
LitVar | rs12130333 |
Map | rs12130333 |
PheGenI | rs12130333 |
Biobank | rs12130333 |
1000 genomes | rs12130333 |
hgdp | rs12130333 |
ensembl | rs12130333 |
geneview | rs12130333 |
scholar | rs12130333 |
rs12130333 | |
pharmgkb | rs12130333 |
gwascentral | rs12130333 |
openSNP | rs12130333 |
23andMe | rs12130333 |
SNPshot | rs12130333 |
SNPdbe | rs12130333 |
MSV3d | rs12130333 |
GWAS Ctlg | rs12130333 |
GMAF | 0.1185 |
Max Magnitude | 0 |
? | (C;C) (C;T) (T;T) | 28 |
---|---|---|
|
GWAS | |
---|---|
SNP | rs12130333 |
PubMedID | [PMID 18193044] |
Condition | Triglycerides |
Gene | ANGPTL3, DOCK7, ATG4C |
Risk Allele | C |
pValue | 2.00E-008 |
OR | 0.11 |
95% CI | 0.07-0.15) % SD lowe |
[PMID 19656773] A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia
[PMID 18596051] Polygenic determinants of severe hypertriglyceridemia.
[PMID 19060910] Genome-wide association analysis of metabolic traits in a birth cohort from a founder population.
[PMID 19197348] Genome-wide association studies in an isolated founder population from the Pacific Island of Kosrae.
[PMID 19802338] Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication.
[PMID 21691831] Triglyceride level-influencing functional variants of the ANGPTL3, CILP2, and TRIB1 loci in ischemic stroke.
[PMID 22896670] Interaction between SNPs in the RXRA and near ANGPTL3 gene region inhibits apoB reduction after statin-fenofibric acid therapy in individuals with mixed dyslipidemia.